Search results (118)
« Back to PublicationsReperfusion grade and clinical outcome following medium vessel occlusion thrombectomy in the Endovascular Treatment to Improve Outcomes for Medium Vessel Occlusions (ESCAPE-MeVO) Trial.
Journal article
Diprose W. et al, (2026), J Neurointerv Surg
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical Trial.
Journal article
Zhang Y. et al, (2025), JAMA Neurol, 82, 1243 - 1250
Impact of Cerebral Embolic Protection on Cognitive Function After Transcatheter Aortic Valve Implantation: Data From the BHF PROTECT-TAVI Randomized Trial.
Journal article
Kennedy J. et al, (2025), Circulation, 152, 1268 - 1278
Literature review and DELPHI consensus on follow-up and retreatment of intracranial aneurysms with intrasaccular devices.
Journal article
Stebner A. et al, (2025), Interv Neuroradiol
ccommodating Asymmetric Adherence in Clinical Trial Analyses: Insights From BHF PROTECT-TAVI.
Journal article
Kennedy J. et al, (2025), J Am Coll Cardiol, 86, 829 - 831
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation.
Journal article
Kharbanda RK. et al, (2025), N Engl J Med, 392, 2403 - 2412
Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferiority trial
Journal article
Anderson CS. et al, (2025), Lancet, 405, 1909 - 1922
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO-2 Trial.
Journal article
Yu AYX. et al, (2025), J Am Heart Assoc, 14
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.
Journal article
Goyal M. et al, (2025), N Engl J Med, 392, 1385 - 1395
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.
Journal article
Muir KW. et al, (2024), Lancet Neurol, 23, 1087 - 1096
Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial.
Journal article
Ospel JM. et al, (2024), Int J Stroke, 19, 1064 - 1070
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Journal article
Coutts SB. et al, (2024), Lancet, 403, 2597 - 2605
cute ischemic STROKE - from laboratory to the Patient's BED (STROKELABED): A translational approach to reperfusion injury. Study Protocol.
Journal article
Sodero A. et al, (2024), Transl Neurosci, 15
THE POTENTIAL ROLE OF NEURON-SPECIFIC ENOLASE AS A PREDICTOR OF FINAL INFARCT VOLUME IN STROKE PATIENTS. PRELIMINARY RESULTS FROM THE NIMBLE STUDY
Conference paper
Sodero A. et al, (2024), INTERNATIONAL JOURNAL OF STROKE, 19, 127 - 128
THE POTENTIAL ROLE OF ALFA-2 MACROGLOBULINE AND S100B PROTEIN AS PREDICTORS OF FUNCTIONAL OUTCOME IN ACUTE STROKE PATIENTS. PRELIMINARY RESULTS FROM THE NIMBLE STUDY
Conference paper
Sodero A. et al, (2024), INTERNATIONAL JOURNAL OF STROKE, 19, 43 - 44